发明授权
US09572777B2 Topical pharmaceutical composition comprising nanonized silver sulfadiazine
有权
局部药物组合物包含纳米化的磺胺嘧啶银
- 专利标题： Topical pharmaceutical composition comprising nanonized silver sulfadiazine
- 专利标题（中）： 局部药物组合物包含纳米化的磺胺嘧啶银
-
申请号： US15090985申请日： 2016-04-05
-
公开(公告)号： US09572777B2公开(公告)日： 2017-02-21
- 发明人: Neeta Gupta , Simrata Bedi , Jyoti Srivastava , Vinod Kumar Arora , Manisha Pandya , Vyas M. Shingatgeri , Jaiprakash Jaysingrao Bhelonde , Monika Obrah , Sanjay Kumar Sharma , Rajinder K. Jalali , Sudershan Kumar Arora
- 申请人： SUN PHARMACEUTICAL INDUSTRIES LIMITED
- 申请人地址： IN Mumbai
- 专利权人： SUN PHARMACEUTICAL INDUSTRIES LIMITED
- 当前专利权人： SUN PHARMACEUTICAL INDUSTRIES LIMITED
- 当前专利权人地址： IN Mumbai
- 优先权： IN1821/DEL/2010 20100802; IN2690/DEL/2012 20120830
- 主分类号： A61K39/108
- IPC分类号： A61K39/108 ; A61K9/14 ; A61K33/38 ; A61K9/00 ; A61K31/155 ; A61K31/555 ; A61K31/635
摘要：
The invention relates to a topical pharmaceutical composition for burn treatment and microbial infections on human beings or animals. The pharmaceutical composition comprises 0.1% w/w to 1.0% w/w of an antimicrobial drug, i.e., silver sulfadiazine and 0.2% w/w antiseptic, i.e., chlorhexidine gluconate, wherein silver sulfadiazine is in nanonized form.
公开/授权文献
信息查询
